SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-14-208033
Filing Date
2014-05-21
Accepted
2014-05-21 15:21:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d732450dsc13g.htm SC 13G 48764
  Complete submission text file 0001193125-14-208033.txt   50173
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-46083 | Film No.: 14860554
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1221 RIVERBEND DR STE 120 DALLAS TX 75247
Business Address
MEAD ROBERT E (Filed by) CIK: 0001040747 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000